» Articles » PMID: 39117836

Murine Models of Secondary Cytokine Storm Syndromes

Overview
Date 2024 Aug 8
PMID 39117836
Authors
Affiliations
Soon will be listed here.
Abstract

Hemophagocytic lymphohistiocytosis (HLH) comprises a broad spectrum of life-threatening cytokine storm syndromes, classified into primary (genetic) or secondary (acquired) HLH. The latter occurs in a variety of medical conditions, including infections, malignancies, autoimmune and autoinflammatory diseases, acquired immunodeficiency, and metabolic disorders. Despite recent advances in the field, the pathogenesis of secondary HLH remains incompletely understood. Considering the heterogeneity of triggering factors and underlying diseases in secondary HLH, a large diversity of animal models has been developed to explore pivotal disease mechanisms. To date, over 20 animal models have been described that each recapitulates certain aspects of secondary HLH. This review provides a comprehensive overview of the existing models, highlighting relevant findings, discussing the involvement of different cell types and cytokines in disease development and progression, and considering points of interest toward future therapeutic strategies.

Citing Articles

Animal Models of Human Disease 2.0.

Lange S, Inal J Int J Mol Sci. 2025; 25(24.

PMID: 39769507 PMC: 11679604. DOI: 10.3390/ijms252413743.

References
1.
Jordan M, Hildeman D, Kappler J, Marrack P . An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004; 104(3):735-43. DOI: 10.1182/blood-2003-10-3413. View

2.
Crozat K, Hoebe K, Ugolini S, Hong N, Janssen E, Rutschmann S . Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med. 2007; 204(4):853-63. PMC: 2118559. DOI: 10.1084/jem.20062447. View

3.
Krebs P, Crozat K, Popkin D, Oldstone M, Beutler B . Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood. 2011; 117(24):6582-8. PMC: 3123024. DOI: 10.1182/blood-2011-01-329607. View

4.
Pachlopnik Schmid J, Ho C, Diana J, Pivert G, Lehuen A, Geissmann F . A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). Eur J Immunol. 2008; 38(11):3219-25. DOI: 10.1002/eji.200838488. View

5.
Kogl T, Muller J, Jessen B, Schmitt-Graeff A, Janka G, Ehl S . Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood. 2012; 121(4):604-13. DOI: 10.1182/blood-2012-07-441139. View